# Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention

> **NCT03476369** · PHASE4 · TERMINATED · sponsor: **The Guthrie Clinic** · enrollment: 45 (actual)

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Ticagrelor 90Mg Tablet

## Key facts

- **NCT ID:** NCT03476369
- **Lead sponsor:** The Guthrie Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-18
- **Primary completion:** 2025-01-23
- **Final completion:** 2025-01-23
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Researcher stopped study due to slow accrual rate
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03476369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03476369, "Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03476369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*